Breast cancer

Tadashi Ikeda, Hiromitsu Jinno, Akira Matsui, Yoko Mitsui, Sota Asaga, Takeshi Muto, Masahiro Wada, Masaki Kitajima

研究成果: Review article

抜粋

Adjuvant chemo-endocrine therapy for breast cancer (ACETBC) trial has been the first large scaled clinical trial performed in Japan. Several prospective randomized trials have been performed in Japan since ACETBC-1 trial started in 1985. The effect of oral 5-FU agents had been tested in prospective randomized trials and the statistically marginal effect of oral 5-FU agents in adjuvant settings has been reported. Several trials having CMF as a control arm started in 1996 when CMF combination chemotherapy was approved by the government. The results of these trials have not been published. To perform good clinical trials, it is imperative to construct infrastructures including clinical research coordinator, and abolish governmental regulation of the dose of anticancer agents.

元の言語English
ページ(範囲)1509-1515
ページ数7
ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
29
発行部数9
出版物ステータスPublished - 2002 9

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント Breast cancer' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Ikeda, T., Jinno, H., Matsui, A., Mitsui, Y., Asaga, S., Muto, T., Wada, M., & Kitajima, M. (2002). Breast cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 29(9), 1509-1515.